Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS
G04B UROLOGICALS
G04BD Urinary antispasmodics
G04BD11 Fesoterodine
D08923 Fesoterodine fumarate (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Genitourinary Agents
Antispasmodics, Urinary
Fesoterodine
D08923 Fesoterodine fumarate (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
25 Urogenital and anal organ agents
259 Miscellaneous
2590 Miscellaneous
D08923 Fesoterodine fumarate (JAN/USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG00483 Fesoterodine
D08923 Fesoterodine fumarate
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00483 Fesoterodine
D08923 Fesoterodine fumarate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00483 Fesoterodine
D08923 Fesoterodine fumarate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM2
D08923 Fesoterodine fumarate (JAN/USAN) <JP/US>
CHRM3
D08923 Fesoterodine fumarate (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08923
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D08923
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D08923
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08923
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08923
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D08923
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG00483 Fesoterodine
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00483 Fesoterodine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00483 Fesoterodine
Other DBs
CAS:
286930-03-8
PubChem:
96025606
LigandBox:
D08923
KCF data
ATOM 38
1 C1c C 15.5400 -14.9800
2 N1c N 16.7300 -15.6800
3 C1b C 17.9200 -15.0500
4 C1b C 19.1100 -15.7500
5 C1c C 20.4400 -15.0500
6 C8y C 21.6300 -15.7500
7 C8x C 22.8200 -15.0500
8 C8y C 24.0800 -15.7500
9 C1b C 25.2700 -15.1200
10 C1a C 15.5400 -13.5800
11 C1c C 16.7300 -17.1500
12 C1a C 15.4700 -17.7800
13 C1a C 17.9900 -17.7800
14 C8y C 21.6300 -17.1500
15 C8x C 24.0800 -17.1500
16 C8x C 22.8200 -17.8500
17 O7a O 20.4400 -17.7800
18 O1a O 26.4600 -15.8200
19 C1a C 14.3500 -15.6800
20 C8y C 20.4400 -13.5800
21 C8x C 21.7000 -12.8800
22 C8x C 21.7000 -11.4800
23 C8x C 20.5100 -10.7800
24 C8x C 19.2500 -11.4100
25 C8x C 19.2500 -12.8100
26 C7a C 20.4400 -19.1800
27 O6a O 21.7000 -19.8100
28 C1c C 19.2500 -19.8800
29 C1a C 18.0600 -19.1800
30 C1a C 19.2500 -21.2800
31 O6a O 31.5700 -16.7300
32 C6a C 32.7824 -16.0300
33 C2b C 33.9949 -16.7300
34 C2b C 35.2073 -16.0300
35 C6a C 36.4197 -16.7300
36 O6a O 37.6322 -16.0300
37 O6a O 32.7824 -14.6302
38 O6a O 36.4197 -18.1299
BOND 38
1 1 2 1
2 2 3 1
3 3 4 1
4 5 4 1
5 5 6 1
6 6 7 1
7 7 8 2
8 8 9 1
9 1 10 1
10 2 11 1
11 11 12 1
12 11 13 1
13 6 14 2
14 8 15 1
15 14 16 1
16 16 15 2
17 14 17 1
18 9 18 1
19 1 19 1
20 5 20 1 #Down
21 20 21 2
22 21 22 1
23 22 23 2
24 23 24 1
25 24 25 2
26 20 25 1
27 17 26 1
28 26 27 2
29 26 28 1
30 28 29 1
31 28 30 1
32 31 32 1
33 32 33 1
34 33 34 2
35 34 35 1
36 35 36 1
37 32 37 2
38 35 38 2